Kazakhstan vs Togo: Cause of death, by non-communicable diseases, ages 15-59
Kazakhstan
49.1%
in 2021
Togo
49.0%
in 2021
Kazakhstan rank
110th
Togo rank
111th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Kazakhstan
- Togo
How they compare
Kazakhstan currently reports 49.1% against 49.0% in Togo, a difference of 0.1%.
Across all 6 years both countries report, Kazakhstan has been ahead every year.
Kazakhstan ranks 110th and Togo ranks 111th of 185 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.2% | 35.2% | 29.0% | Kazakhstan |
| 2010s | 71.3% | 44.4% | 26.9% | Kazakhstan |
| 2020s | 55.3% | 49.6% | 5.7% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Kazakhstan or Togo?
- Kazakhstan, at 49.1% against 49.0% in Togo as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Kazakhstan and Togo?
- 0.1%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Togo?
- 6 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Togo rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Kazakhstan ranks 110th and Togo ranks 111th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.